Nicolai Haase Selected Research

Starch (Cornstarch)

1/2020	Effects of simulated sample sizes on the mortality effect estimates in three randomized intensive care unit trials.
12/2018	Prediction of bleeding by thromboelastography in ICU patients with haematological malignancy and severe sepsis.
10/2016	High Levels of Methylarginines Were Associated With Increased Mortality in Patients With Severe Sepsis.
4/2016	Markers of endothelial damage and coagulation impairment in patients with severe sepsis resuscitated with hydroxyethyl starch 130/0.42 vs Ringer acetate.
3/2016	Gone fishing in a fluid trial.
1/2016	Associations of Hospital and Patient Characteristics with Fluid Resuscitation Volumes in Patients with Severe Sepsis: Post Hoc Analyses of Data from a Multicentre Randomised Clinical Trial.
4/2015	Association between biomarkers of endothelial injury and hypocoagulability in patients with severe sepsis: a prospective study.
1/2015	Thromboelastography in patients with severe sepsis: a prospective cohort study.
7/2014	Long-term outcomes in patients with severe sepsis randomised to resuscitation with hydroxyethyl starch 130/0.42 or Ringer's acetate.
6/2014	Individual patient data meta-analysis of hydroxyethyl starch 130/0.4-0.42 versus crystalloid for fluid resuscitation in patients with severe sepsis: a statistical analysis plan.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nicolai Haase Research Topics

Disease

19	Sepsis (Septicemia) 01/2020 - 01/2011
16	Septic Shock (Toxic Shock Syndrome) 01/2020 - 01/2011
7	Hemorrhage 01/2020 - 01/2011
4	COVID-19 01/2022 - 01/2021
4	Acute Kidney Injury (Acute Renal Failure) 04/2013 - 01/2011
3	Critical Illness (Critically Ill) 01/2021 - 06/2014
3	Shock 09/2015 - 01/2011
2	Hypotension (Low Blood Pressure) 01/2021 - 11/2013
2	Neoplasms (Cancer) 12/2018 - 05/2013
2	Renal Insufficiency (Renal Failure) 07/2012 - 01/2011
1	Fatigue 01/2022
1	Superinfection 10/2021
1	Atrial Fibrillation 01/2021
1	Ulcer 10/2019
1	Stroke (Strokes) 01/2019
1	Respiratory Insufficiency (Respiratory Failure) 10/2016
1	Cardiovascular Diseases (Cardiovascular Disease) 10/2016
1	Hypertension (High Blood Pressure) 10/2016
1	Wounds and Injuries (Trauma) 06/2014
1	Myocardial Infarction 06/2014
1	Infections 06/2013
1	Pruritus (Itching) 02/2013
1	Hypersensitivity (Allergy) 01/2011

Drug/Important Bio-Agent (IBA)

18	Starch (Cornstarch)IBA 01/2020 - 01/2011
9	Ringer's acetateIBA 01/2020 - 01/2011
3	Crystalloid SolutionsIBA 06/2014 - 01/2011
3	Hydroxyethyl Starch Derivatives (Pentastarch)FDA Link 06/2014 - 01/2011
3	Colloids (Colloid)IBA 03/2014 - 01/2011
2	Norepinephrine (Noradrenaline)FDA LinkGeneric 01/2021 - 06/2014
2	Pantoprazole (Protonix)FDA LinkGeneric 01/2020 - 10/2019
2	Biomarkers (Surrogate Marker)IBA 04/2015 - 06/2014
1	Anti-Bacterial Agents (Antibiotics)IBA 10/2021
1	CreatinineIBA 10/2016
1	BilirubinIBA 10/2016
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 10/2016
1	Arginine (L-Arginine)FDA Link 10/2016
1	Acetates (Acetic Acid Esters)FDA Link 04/2016
1	Fibrinogen (Factor I)FDA Link 01/2015
1	Hemoglobins (Hemoglobin)IBA 10/2014
1	CatecholaminesIBA 06/2014
1	Hemostatics (Antihemorrhagics)IBA 12/2013
1	Lactic Acid (Lactate)FDA LinkGeneric 11/2013
1	Mannitol (Osmitrol)FDA LinkGeneric 05/2013
1	Glucose (Dextrose)FDA LinkGeneric 05/2013
1	Adenine FDA LinkGeneric 05/2013
1	Lipocalin-2IBA 04/2013
1	theasinensin AIBA 02/2013
1	Human Serum Albumin FDA LinkGeneric 02/2013
1	AlbuminsIBA 02/2013
1	HES 130-0.4IBA 01/2011

Therapy/Procedure

12	Resuscitation 11/2016 - 01/2011
5	Critical Care (Surgical Intensive Care) 01/2022 - 08/2011
5	Renal Replacement Therapy (Therapies, Renal Replacement) 01/2022 - 01/2011
3	Length of Stay 01/2022 - 01/2019
2	Artificial Respiration (Mechanical Ventilation) 01/2022 - 01/2021
2	Therapeutics 10/2021 - 06/2013
2	Fluid Therapy (Oral Rehydration Therapy) 01/2016 - 02/2013
2	Erythrocyte Transfusion 02/2014 - 05/2013
1	Investigational Therapies (Experimental Therapy) 01/2022
1	Activities of Daily Living (ADL) 01/2022
1	CARE protocol 11/2016
1	Blood Transfusion (Blood Transfusions) 10/2014
1	Mechanical Ventilators (Ventilator) 01/2011